CIK 0001540159 · Non-accelerated filer<br>Smaller reporting company
Edesa Biotech, Inc.
Sign in to watch- Ticker
- EDSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (905) 475-1234
- Business address
- C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
- Former names
- Stellar Biotechnologies, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Executive or director change · Shareholder vote results
- 4 Open-market buy Chief Executive Officer bought 2,000 shares at $5.23 ($10,460)
- 4 Open-market buy Chief Executive Officer bought 3,000 shares at $5.25 ($15,750)
- 4 Open-market buy President bought 3,500 shares at $5.19 ($18,165)
- 4 Open-market buy President bought 4,500 shares at $5.08 ($22,860)
- 4 Open-market buy Chief Executive Officer bought 5,000 shares at $5.16 ($25,800)
- 8-K Event Material agreement
- DEF 14A Proxy Proxy Statement
- 424B5 Offering Prospectus
- 8-K/A Event Material agreement · Agreement ended
- 8-K Event Material agreement · Agreement ended
- FWP Offering Free Writing Prospectus
- 424B5 Offering Prospectus
- FWP Offering Free Writing Prospectus
Page 16 of 38 · 753 filings